Brief: Benitec Biopharma Discloses Q2 2022 Financial Results

Benitec Biopharma

14/02/2022 14:32

Feb 14 (Reuters) - Benitec Biopharma Inc  BNTC.O :
    * BENITEC BIOPHARMA DISCLOSES Q2 2022 FINANCIAL RESULTS
    * BENITEC BIOPHARMA INC - QTRLY NET LOSS PER SHARE $0.59

Source text for Eikon:  ID:nPnbJFZPMa 
Further company coverage:  BNTC.O